KAITLIN CURLEE: Open Payments
NPI 1396261509 · PORT RICHEY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,805 in 112 payments from 20 companies in 2025. Trend: 2023 $2,168 · 2024 $2,428 · 2025 $2,805
Food & beverage: $2,753Education: $52
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 23 | $699 |
| AstraZeneca Pharmaceuticals LP | 23 | $544 |
| Paratek Pharmaceuticals, Inc. | 2 | $284 |
| GlaxoSmithKline, LLC. | 12 | $237 |
| Amgen Inc. | 13 | $178 |
| Novartis Pharmaceuticals Corporation | 6 | $135 |
| Genentech USA, Inc. | 4 | $107 |
| PFIZER INC. | 4 | $92 |
| Galderma Laboratories, L.P. | 5 | $89 |
| CSL Behring | 5 | $88 |
Products named: DUPIXENT, AIRSUPRA, TEZSPIRE, FASENRA, NUZYRA, TRELEGY ELLIPTA, Xolair, XHANCE.
Industry payments across FL — which companies pay providers there.
